Search
Search Results
##search.searchResults.foundPlural##
-
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12241PDF: 1632HTML: 4142Cover letter: 181Figure 1: 175 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4662PDF: 1742HTML: 2100 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3212PDF: 2221HTML: 23290Untitled: 186Untitled: 192Untitled: 210 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1193PDF: 838HTML: 1096Coverletter: 176 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1807PDF: 1096HTML: 1733 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 980HTML: 5497 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1623PDF: 1059HTML: 10688Untitled: 163 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1297HTML: 368PDF: 793 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3501PDF: 834HTML: 6695 -
Anemia in the elderly: not always what it seems.
3235PDF: 987HTML: 1752Figure 1: 158Figure 1 revised: 163 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
877PDF: 547HTML: 308 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3131PDF: 1022HTML: 413 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2516PDF: 775HTML: 5175 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
901PDF: 1180HTML: 89 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1411PDF: 513HTML: 661 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1873PDF: 836HTML: 1262 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1426PDF: 894HTML: 208 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3634PDF: 1604HTML: 11482Figures Haase: 177 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1869PDF: 706HTML: 678 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1053PDF: 816HTML: 220 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2094PDF: 804HTML: 908Patient’s family tree: 150 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1134PDF: 724HTML: 1331Figure 1: 160Figure 2: 159 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1165PDF: 732HTML: 296 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1985PDF: 1600HTML: 345
1 - 41 of 41 items







